期刊文献+

降钙素原和超敏C反应蛋白与急性冠脉综合征患者GRACE评分的相关性及其对预后的评估价值 被引量:1

The correlation and value in assessment of prognosis between procalcitonin,hs-CRP and GRACE risk score in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨降钙素原(PCT)和超敏C反应蛋白(hs-CRP)与急性冠脉综合征(ACS)患者全球急性冠状动脉事件注册(GRACE)评分的相关性,以及PCT、hs-CRP对ACS预后的评估价值。方法回顾性分析2013年1月~2014年12月甘肃省人民医院心内科确诊为ACS的患者192例,根据院内发生心血管事件情况分为未发生心血管事件组和发生心血管事件组,比较两组间基线资料以及PCT、hs-CRP和GRACE评分等指标;所有研究对象按照GRACE评分分为低危组、中危组、高危组,比较各组间PCT、hs-CRP水平;PCT、hs-CRP与GRACE评分的相关性采用Pearson相关分析;绘制受试工作者特征曲线(ROC),评价PCT、hs-CRP对ACS预后的判断价值。结果 192例ACS患者中,住院期间19例发生心血管事件;PCT[(0.098±0.038)ng/ml vs(0.053±0.036)ng/ml,P=0.000]、hs-CRP(12.50±16.11)mg/L vs(2.68±3.55)mg/L,P=0.016]、GRACE评分[(183.9±46.8)vs(137.6±37.4),P=0.000]心血管事件组明显高于未发生心血管事件组。随着GRACE评分升高,PCT、hs-CRP水平逐渐升高,低危组、中危组、高危组PCT分别为(0.042±0.024)ng/ml、(0.057±0.043)ng/ml、(0.071±0.036)ng/ml,hs-CRP分别为(0.85±1.99)mg/L、(2.32±2.48)mg/L、(7.90±10.43)mg/L,PCT、hs-CRP在GRACE评分各分层间两两比较差异均有统计学意义(P均〈0.05)。PCT、hs-CRP水平与GRACE评分均呈显著正相关(r=0.399,r=0.605,P均〈0.01)。PCT、hs-CRP评价ACS预后的ROC曲线分析显示,PCT曲线下面积(AUC):0.827,95%可信区间:0.757~0.897,P〈0.001,敏感度:84.2%,特异度:76.5%;hs-CRP曲线下面积:0.812,95%可信区间:0.722~0.903,P〈0.001,敏感度:89.5%,特异度:66.5%。结论 PCT、hs-CRP与ACS患者GRACE评分显著相关,对预测ACS预后具有一定价值。 Objective To investigate the correlation between procalcitonin (PCT), hs-CRP and GRACE risk score, and explore the value of PCT, hs-CRP in assessment of prognosis in patients with ACS. Methods A total of 192 patients with ACS from Jan 2013 to Dee 2014 in cardiovascular department of Gansu Provincial Hospital were prospectively included. All patients were divided into cardiovascular events group and without cardiovascular events group according to the occurrence of cardiovascular events, then divided into low risk group, moderate risk group and high risk group according to the GRACE risk score. The relationships between PCT, hs-CRP and GRACE risk score were analyzed by Pearson correlation analysis. Receiver operating characteristic (ROC) curve was plotted to assess the prognostic value of PCT and hs-CRP for prognosis of patients with ACS. Results During the in-hospital period, 19 patients presented cardiovascular events. The blood level of PCT [(0.098±0.038)ng/ml vs (0.053±0.036)ng/ml, P=0.000], hs-CRP [(12.50±16.11)mg/L vs (2.68±3.55)mg/L, P=0.016)] and GRACE risk score [(183.9±46.8) vs (137.6±37.4), P=0.000] in cardiovascular events group were significantly higher than without cardiovascular events group. The values of PCT, hs-CRP rose significantly as the GRACE risk score became higher. Inthe low risk group, moderate risk group and high risk group, the value of PCT was (0.042±0.024)ng/ml, (0.057±0.043)ng/ml, (0.071±0.036)ngtml, and the value of hs-CRP was (0.85±1.99)mg/L, (2.32±2.48)mg/L, (7.90±10.43)mg/L respectively. There were significant differences in PCT and hs-CRP between any two groups with different GRACE risk score. The values of PCT and hs-CRP were significantly correlated with GRACE risk score (r=0.399, r=0.605, both P〈0.01). ROC curve presented that PCT (AUC: 0.827, 95%CI: 0.757-0.897, P〈0.001, sensitivity: 84.2%, specificity: 76.5%) and hs-CRP (AUC: 0.812, 95% CI: 0.722-0.903, P〈0.001, sensitivity: 89.5%, specificity: 66.5%) were related to prognosis in patients with ACS. Conclusion The levels of PCT and hs-CRP are significantly correlated with GRACE risk score, which has a certain value in assess- ment of prognosis in patients with ACS.
出处 《中国现代医药杂志》 2015年第12期16-19,共4页 Modern Medicine Journal of China
关键词 降钙素原 超敏C反应蛋白 GRACE评分 急性冠脉综合征 预后 Procalcitonin High sensitive C-reactive protein Global registry of acute coronary events score Acute coronary syndrome Prognosis
  • 相关文献

参考文献15

  • 1Irwin A ,Carrol D. Archives of disease in childhood-education and practice edition[J]. Procalcitonin, 2011,96(6) :228-233.
  • 2Ataog H, Yilmaz F, Uzunhasan I, et al. Procalcitonin : a novel car- diac marker with prognostic value in acute coronary syndrome[J]. The Journal of International Medical Research, 2010,38 ( 1 ) : 52-61.
  • 3Correia L,Esteves J. C-Reactive protein and outcomes in acute coronary syndromes: a systematic review and meta-analysis [J].Arq Bras Cardio1,2011,97( 1 ) :76-85.
  • 4Gray H,Henderson R. The GRACE score's performance in predict- ing in-hospital and 1-year outcome[J]. Heart, 2011,38 ( 1 ) : 52-61.
  • 5Michael E. Inflammation and atherosclerosis: direct versus indi- rect mechanisms[J]. Current Opinion in Pharmacology,2013,13 (2) : 154-160.
  • 6柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2117
  • 7无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690. 被引量:1955
  • 8Granger C, Goldberg R, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events[J]. Arch Intern Med ,2003,163(5) :45-53.
  • 9Correia L,Freitas R,Bitteneourt A,et al. Prognostic value of GRACE scores versus TIMI score in acute coronary syndromes[J]. Arq Bras Cardio1,2010,94 (5) :613-619.
  • 10孙艺红,胡大一,闰明珠.非ST段抬高急性冠状动脉综合征的预后危险因素与危险评分[J].中国循环杂志,2006,21(1):8-11. 被引量:34

二级参考文献58

  • 1邓石雄.和肽素和降钙素原及其他炎症指标在脑卒中患者发生感染中的预测价值[J].中国老年学杂志,2014,34(8):2048-2050. 被引量:15
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 3Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 4Antman EM, Cohen M, Bernink PJLM,et al. The TIMI risk score for unstable angina/non-ST elevation MI. JAMA ,2000,284:835-842.
  • 5Granger CB, Goldberg RJ, Dabbous OH ,et al. For the global registry of acute coronary events investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med,2003,163:2345-2353.
  • 6Diderholm E, Andren B, Frostfeldt G, et al. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC Ⅱ invasive troponin T electrocardiogram substudy, Am Heart J, 2002,143: 760-767.
  • 7AI Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation, 2002,106:974-980.
  • 8Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coil Cardiol, 2002,39 : 1113-1119.
  • 9Shlipak MG, Heidenreich PA, Noguchi ti, et al. Association of renal in-sufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med,2002 ,137 :555-562.
  • 10Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA, 1987,258 : 1183-1186.

共引文献3985

同被引文献8

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部